New cholera vaccine enters final testing phase in south africa

NCT ID NCT07304284

Recruiting now ⭐️ VACCINE ⭐️ Sponsor: International Vaccine Institute Source: ClinicalTrials.gov ↗

Summary

This study is testing a new oral cholera vaccine called Biovac OCV-S to see if it works as well as an already approved vaccine. It will involve 2,824 healthy children and adults, and adults living with HIV, in South Africa. Participants will receive two doses of either the new vaccine or the existing one, and researchers will compare how well they trigger an immune response and their safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Perinatal HIV Research Unit (PHRU)
RECRUITING

Johannesburg, Gauteng, 1862, South Africa

Contact Phone: •••-•••-•••• Email: •••••@•••••
SAMRC Chatworth CRS
RECRUITING

Durban, KwaZulu-Natal, 4092, South Africa

Contact Phone: •••-•••-•••• Email: •••••@•••••
SAMRC Isipingo CRS
NOT_YET_RECRUITING

Durban, KwaZulu-Natal, 4110, South Africa

Contact Phone: •••-•••-•••• Email: •••••@•••••
Synergy Biomed Research Institute
NOT_YET_RECRUITING

Durban, Eastern Cape, 5201, South Africa

Contact Phone: •••-•••-•••• Email: •••••@•••••
Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit
NOT_YET_RECRUITING

Johannesburg, Gauteng, 1862, South Africa

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHOLERA VACCINATION